S298: CS585 IS A FIRST-IN-CLASS COMPOUND TARGETING THE IP RECEPTOR FOR PREVENTION OF THROMBOSIS WITHOUT INCREASED RISK OF BLEEDING
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000844084.73245.8e |
| _version_ | 1797281751440031744 |
|---|---|
| author | S. Lambert R. Adili P. Yalavarthi N. Rhoads B. Dahlof A. White N. Bergh M. Holinstat |
| author_facet | S. Lambert R. Adili P. Yalavarthi N. Rhoads B. Dahlof A. White N. Bergh M. Holinstat |
| author_sort | S. Lambert |
| collection | DOAJ |
| first_indexed | 2024-03-07T17:01:57Z |
| format | Article |
| id | doaj.art-6f3552ee3404447e8576a299276232c3 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T17:01:57Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-6f3552ee3404447e8576a299276232c32024-03-03T03:19:22ZengWileyHemaSphere2572-92412022-06-01619920010.1097/01.HS9.0000844084.73245.8e202206003-00199S298: CS585 IS A FIRST-IN-CLASS COMPOUND TARGETING THE IP RECEPTOR FOR PREVENTION OF THROMBOSIS WITHOUT INCREASED RISK OF BLEEDINGS. Lambert0R. Adili1P. Yalavarthi2N. Rhoads3B. Dahlof4A. White5N. Bergh6M. Holinstat71 Pharmacology, University of Michigan Medical School, Ann Arbor, United States of America1 Pharmacology, University of Michigan Medical School, Ann Arbor, United States of America1 Pharmacology, University of Michigan Medical School, Ann Arbor, United States of America1 Pharmacology, University of Michigan Medical School, Ann Arbor, United States of America2 Cereno Scientific4 Medicinal Chemistry2 Cereno Scientific1 Pharmacology, University of Michigan Medical School, Ann Arbor, United States of Americahttp://journals.lww.com/10.1097/01.HS9.0000844084.73245.8e |
| spellingShingle | S. Lambert R. Adili P. Yalavarthi N. Rhoads B. Dahlof A. White N. Bergh M. Holinstat S298: CS585 IS A FIRST-IN-CLASS COMPOUND TARGETING THE IP RECEPTOR FOR PREVENTION OF THROMBOSIS WITHOUT INCREASED RISK OF BLEEDING HemaSphere |
| title | S298: CS585 IS A FIRST-IN-CLASS COMPOUND TARGETING THE IP RECEPTOR FOR PREVENTION OF THROMBOSIS WITHOUT INCREASED RISK OF BLEEDING |
| title_full | S298: CS585 IS A FIRST-IN-CLASS COMPOUND TARGETING THE IP RECEPTOR FOR PREVENTION OF THROMBOSIS WITHOUT INCREASED RISK OF BLEEDING |
| title_fullStr | S298: CS585 IS A FIRST-IN-CLASS COMPOUND TARGETING THE IP RECEPTOR FOR PREVENTION OF THROMBOSIS WITHOUT INCREASED RISK OF BLEEDING |
| title_full_unstemmed | S298: CS585 IS A FIRST-IN-CLASS COMPOUND TARGETING THE IP RECEPTOR FOR PREVENTION OF THROMBOSIS WITHOUT INCREASED RISK OF BLEEDING |
| title_short | S298: CS585 IS A FIRST-IN-CLASS COMPOUND TARGETING THE IP RECEPTOR FOR PREVENTION OF THROMBOSIS WITHOUT INCREASED RISK OF BLEEDING |
| title_sort | s298 cs585 is a first in class compound targeting the ip receptor for prevention of thrombosis without increased risk of bleeding |
| url | http://journals.lww.com/10.1097/01.HS9.0000844084.73245.8e |
| work_keys_str_mv | AT slambert s298cs585isafirstinclasscompoundtargetingtheipreceptorforpreventionofthrombosiswithoutincreasedriskofbleeding AT radili s298cs585isafirstinclasscompoundtargetingtheipreceptorforpreventionofthrombosiswithoutincreasedriskofbleeding AT pyalavarthi s298cs585isafirstinclasscompoundtargetingtheipreceptorforpreventionofthrombosiswithoutincreasedriskofbleeding AT nrhoads s298cs585isafirstinclasscompoundtargetingtheipreceptorforpreventionofthrombosiswithoutincreasedriskofbleeding AT bdahlof s298cs585isafirstinclasscompoundtargetingtheipreceptorforpreventionofthrombosiswithoutincreasedriskofbleeding AT awhite s298cs585isafirstinclasscompoundtargetingtheipreceptorforpreventionofthrombosiswithoutincreasedriskofbleeding AT nbergh s298cs585isafirstinclasscompoundtargetingtheipreceptorforpreventionofthrombosiswithoutincreasedriskofbleeding AT mholinstat s298cs585isafirstinclasscompoundtargetingtheipreceptorforpreventionofthrombosiswithoutincreasedriskofbleeding |